Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HER2 (ERBB2) is a transmembrane receptor tyrosine kinase that plays a critical role in cell proliferation, survival, differentiation, and migration. It is a member of the EGFR/HER family and is frequently overexpressed or amplified in various cancers, making it an important therapeutic target. HER2 activates downstream signaling pathways such as MAPK and PI3K-AKT upon dimerization.
Monoclonal antibodies, antibody-drug conjugates, small molecule inhibitors targeting kinase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Epidermal Growth Factor Receptor 2 Tyrosine Kinase (HER2).